ETON PHARMACEUTICALS

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

04 أكتوبر 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

23 أغسطس 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

10 أغسطس 2023 15:01:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

01 أغسطس 2023 15:05:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 يونيو 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 مايو 2023 15:01:01 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 مايو 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 مايو 2023 15:05:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 مارس 2023 15:01:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 مارس 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 مارس 2023 15:05:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 يناير 2023 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 نوفمبر 2022 15:05:01 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 نوفمبر 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 أكتوبر 2022 05:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 سبتمبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 أغسطس 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 أغسطس 2022 15:01:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 أغسطس 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 يوليو 2022 06:05:00 بحسب Nasdaq GlobeNewswire